APOS
Herzliya, US · 1 known investors
Find your way into APOS
Sign up to see every warm intro you have to APOS
- Paths you didn't know you had: your email and LinkedIn already hold routes to the APOS team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AposHealth offers Apos, an FDA-cleared, foot-worn medical device personalized to each patient's biomechanics to treat knee osteoarthritis, chronic hip pain, and non-specific back pain, delivered as an at-home program supervised by a licensed physical therapist. It serves adults with chronic musculoskeletal joint pain seeking to avoid surgery or reduce medication, with access through VA benefits, commercial insurance, FSA/HSA, and UK referral pathways.
Founders & leadership
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$23.1M disclosed across 3 rounds · 2014–2016
▶$2.5MraisedAug 2016 · 34 investors · Other TechnologyRule 506(b)
- Oded GriffelExecutive Officer
- Michael StockerDirector
- David Levy LevyExecutive Officer, Director
- John CoxExecutive Officer
- Alan MilburnDirector
- Donald AlmeidaDirector
- Ruth AlonDirector
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- First sale
- Jun 2016
- Incorporated
- Corporation, Israel
- Federal exemptions
- 06b
▶$5.3MraisedFeb 2016 · 17 investors · Other TechnologyRule 506(b)
- Michael StockerDirector
- Oded GriffelExecutive Officer
- Alan MilburnDirector
- Amit MorExecutive Officer, Director
- John J. CoxExecutive Officer
- David LevyExecutive Officer, Director
- Avi ElbazExecutive Officer, Director
- Ruth AlonDirector
- Donald AlmeidaDirector
- Offering amount
- $6M
- Amount sold
- $5.3M
- First sale
- Dec 2015
- Incorporated
- Corporation, Israel
- Federal exemptions
- 06b
▶$15.3MraisedDec 2014 · 46 investors · Other Health CareRule 506(b)
- Donald AlmeidaDirector
- Ruth AlonDirector
- Avi ElbazExecutive Officer, Director
- Alan MilburnDirector
- David LevyExecutive Officer, Director
- Limor SchwartzExecutive Officer
- Michael StockerDirector
- Amit MorExecutive Officer, Director
- Oded GriffelExecutive Officer
- Offering amount
- $18M
- Amount sold
- $15.3M
- Minimum investment
- $5K
- First sale
- Nov 2014
- Incorporated
- Corporation, Israel
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does APOS do?
- AposHealth offers Apos, an FDA-cleared, foot-worn medical device personalized to each patient's biomechanics to treat knee osteoarthritis, chronic hip pain, and non-specific back pain, delivered as an at-home program supervised by a licensed physical therapist. It serves adults with chronic musculoskeletal joint pain seeking to avoid surgery or reduce medication, with access through VA benefits, commercial insurance, FSA/HSA, and UK referral pathways.
- Who founded APOS?
- APOS was founded by Amit Mor, Avi Elbaz.
- Who are APOS's investors?
- APOS's investors include Aviv Venture Capital.
- How much funding has APOS raised?
- APOS has disclosed $23.1M raised across 3 rounds.
- Where is APOS headquartered?
- APOS is headquartered in Herzliya, US.



